“Renal safety of combined cyclooxygenase 2 (COX-2) inhibitor and angiotensin II receptor blocker administration in mild volume depletion”, Swiss Med Wkly, vol. 131, no. 1314, pp. 193–198, Apr. 2001, doi: 10.4414/smw.2001.09680.